Dyadic International Inc, DE (DYAI) Implied Volatility Current

Tracking DYAI implied volatility helps you identify when options premiums on Dyadic International Inc, DE are historically cheap or expensive, and where the best trades are hiding. Dyadic International Inc, DE implied volatility reflects the market's expectation of future price movement: when DYAI IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Dyadic International Inc, DE's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For DYAI, tracking metrics like DYAI IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on DYAI signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.

The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where DYAI implied volatility sits today versus where it has been. Our scanner ranks Dyadic International Inc, DE implied volatility against its historical range, surfaces extremes in DYAI IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Dyadic International Inc, DE IV is rich or cheap — measure it, then act on it.